1. Home
  2. HYFM vs AIDX Comparison

HYFM vs AIDX Comparison

Compare HYFM & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

N/A

Current Price

$0.84

Market Cap

4.5M

Sector

Industrials

ML Signal

N/A

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.38

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HYFM
AIDX
Founded
1977
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Precision Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.9M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
HYFM
AIDX
Price
$0.84
$0.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.5K
★ 54.7K
Earning Date
11-11-2026
11-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.48
EPS
N/A
★ N/A
Revenue
★ $134,252,000.00
$2,045,133.00
Revenue This Year
$54.93
$44.20
Revenue Next Year
$5.31
$95.73
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.71
52 Week Low
$0.50
$0.33
52 Week High
$3.42
$14.09

Technical Indicators

Market Signals
Indicator
HYFM
AIDX
Relative Strength Index (RSI) 38.29 35.59
Support Level $0.81 N/A
Resistance Level $1.06 $0.49
Average True Range (ATR) 0.07 0.05
MACD -0.00 -0.00
Stochastic Oscillator 8.67 25.03

Price Performance

Historical Comparison
HYFM
AIDX

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: